학술논문
Pegylated (40 kDa) interferon alfa-2a (PEGASYS®) in combination with Ribavirin, mycophenolate motelil (CellCept®), amantadine, or amantadine plus ribavirin in patients that relapsed on rebetronTM therapy: A preliminary report of a randomized, multicenter efficacy and safety study
Document Type
Abstract
Author
Source
In Gastroenterology April 2001 120(5) Supplement 1:A384-A384
Subject
Language
ISSN
0016-5085